182 related articles for article (PubMed ID: 30923462)
21. Therapeutic effect of Sirtuin 3 on ameliorating nonalcoholic fatty liver disease: The role of the ERK-CREB pathway and Bnip3-mediated mitophagy.
Li R; Xin T; Li D; Wang C; Zhu H; Zhou H
Redox Biol; 2018 Sep; 18():229-243. PubMed ID: 30056271
[TBL] [Abstract][Full Text] [Related]
22. Caveolin-1 knockdown increases the therapeutic sensitivity of lung cancer to cisplatin-induced apoptosis by repressing Parkin-related mitophagy and activating the ROCK1 pathway.
Liu Y; Fu Y; Hu X; Chen S; Miao J; Wang Y; Zhou Y; Zhang Y
J Cell Physiol; 2020 Feb; 235(2):1197-1208. PubMed ID: 31270811
[TBL] [Abstract][Full Text] [Related]
23. Mitochonic acid-5 attenuates TNF-α-mediated neuronal inflammation via activating Parkin-related mitophagy and augmenting the AMPK-Sirt3 pathways.
Huang D; Liu M; Jiang Y
J Cell Physiol; 2019 Dec; 234(12):22172-22182. PubMed ID: 31062359
[TBL] [Abstract][Full Text] [Related]
24. Mst1 regulates colorectal cancer stress response via inhibiting Bnip3-related mitophagy by activation of JNK/p53 pathway.
Li Q; Qi F; Meng X; Zhu C; Gao Y
Cell Biol Toxicol; 2018 Aug; 34(4):263-277. PubMed ID: 29063978
[TBL] [Abstract][Full Text] [Related]
25. Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells.
Wang W; Lu J; Zhu F; Wei J; Jia C; Zhang Y; Zhou L; Xie H; Zheng S
Med Oncol; 2012 Mar; 29(1):70-6. PubMed ID: 21190094
[TBL] [Abstract][Full Text] [Related]
26. Valproic acid reverses sorafenib resistance through inhibiting activated Notch/Akt signaling pathway in hepatocellular carcinoma.
Yang X; Liu J; Liang Q; Sun G
Fundam Clin Pharmacol; 2021 Aug; 35(4):690-699. PubMed ID: 33015852
[TBL] [Abstract][Full Text] [Related]
27. Mammalian STE20-Like Kinase 1 Deletion Alleviates Renal Ischaemia-Reperfusion Injury via Modulating Mitophagy and the AMPK-YAP Signalling Pathway.
Feng J; Li H; Zhang Y; Wang Q; Zhao S; Meng P; Li J
Cell Physiol Biochem; 2018; 51(5):2359-2376. PubMed ID: 30537740
[TBL] [Abstract][Full Text] [Related]
28. Overriding sorafenib resistance via blocking lipid metabolism and Ras by sphingomyelin synthase 1 inhibition in hepatocellular carcinoma.
Lu H; Zhou L; Zuo H; Le W; Hu J; Zhang T; Li M; Yuan Y
Cancer Chemother Pharmacol; 2021 Feb; 87(2):217-228. PubMed ID: 33226447
[TBL] [Abstract][Full Text] [Related]
29. LATS2-mediated YAP1 phosphorylation is involved in HCC tumorigenesis.
Guo C; Wang X; Liang L
Int J Clin Exp Pathol; 2015; 8(2):1690-7. PubMed ID: 25973055
[TBL] [Abstract][Full Text] [Related]
30. Increased effects of 2,5-dimethylcelecoxib on sensitivity of hepatocellular carcinoma cells to sorafenib via CYP3A5 expression and activation of AMPK.
Chen Y; Pan B; Qiu J; Chen Z; Wang X; Tang N
Toxicol In Vitro; 2021 Oct; 76():105226. PubMed ID: 34293431
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of the PINK1-Parkin Pathway Enhances the Lethality of Sorafenib and Regorafenib in Hepatocellular Carcinoma.
Zhang S; Wang Y; Cao Y; Wu J; Zhang Z; Ren H; Xu X; Kaznacheyeva E; Li Q; Wang G
Front Pharmacol; 2022; 13():851832. PubMed ID: 35370635
[TBL] [Abstract][Full Text] [Related]
32. Sestrin 2 confers primary resistance to sorafenib by simultaneously activating AKT and AMPK in hepatocellular carcinoma.
Dai J; Huang Q; Niu K; Wang B; Li Y; Dai C; Chen Z; Tao K; Dai J
Cancer Med; 2018 Nov; 7(11):5691-5703. PubMed ID: 30311444
[TBL] [Abstract][Full Text] [Related]
33. Alleviation of CCCP-induced mitochondrial injury by augmenter of liver regeneration via the PINK1/Parkin pathway-dependent mitophagy.
Zhang J; Chen S; Li Y; Xiao W; An W
Exp Cell Res; 2021 Dec; 409(1):112866. PubMed ID: 34655600
[TBL] [Abstract][Full Text] [Related]
34. Cholesterol sensor SCAP contributes to sorafenib resistance by regulating autophagy in hepatocellular carcinoma.
Li D; Yao Y; Rao Y; Huang X; Wei L; You Z; Zheng G; Hou X; Su Y; Varghese Z; Moorhead JF; Chen Y; Ruan XZ
J Exp Clin Cancer Res; 2022 Mar; 41(1):116. PubMed ID: 35354475
[TBL] [Abstract][Full Text] [Related]
35. Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma.
Lai YL; Wang KH; Hsieh HP; Yen WC
J Biomed Sci; 2022 Jan; 29(1):5. PubMed ID: 35062934
[TBL] [Abstract][Full Text] [Related]
36. Melatonin Attenuates Calcium Deposition from Vascular Smooth Muscle Cells by Activating Mitochondrial Fusion and Mitophagy via an AMPK/OPA1 Signaling Pathway.
Chen WR; Zhou YJ; Yang JQ; Liu F; Wu XP; Sha Y
Oxid Med Cell Longev; 2020; 2020():5298483. PubMed ID: 32377301
[TBL] [Abstract][Full Text] [Related]
37. Phloretin attenuates STAT-3 activity and overcomes sorafenib resistance targeting SHP-1-mediated inhibition of STAT3 and Akt/VEGFR2 pathway in hepatocellular carcinoma.
Saraswati S; Alhaider A; Abdelgadir AM; Tanwer P; Korashy HM
Cell Commun Signal; 2019 Oct; 17(1):127. PubMed ID: 31619257
[TBL] [Abstract][Full Text] [Related]
38. 17β-Estradiol Induces Mitophagy Upregulation to Protect Chondrocytes
Mei R; Lou P; You G; Jiang T; Yu X; Guo L
Front Endocrinol (Lausanne); 2020; 11():615250. PubMed ID: 33613450
[TBL] [Abstract][Full Text] [Related]
39. Targeting glucosylceramide synthase upregulation reverts sorafenib resistance in experimental hepatocellular carcinoma.
Stefanovic M; Tutusaus A; Martinez-Nieto GA; Bárcena C; de Gregorio E; Moutinho C; Barbero-Camps E; Villanueva A; Colell A; Marí M; García-Ruiz C; Fernandez-Checa JC; Morales A
Oncotarget; 2016 Feb; 7(7):8253-67. PubMed ID: 26811497
[TBL] [Abstract][Full Text] [Related]
40. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
